Naveen Yalamanchi is Director & 10% Owner at ROCKET PHARMACEUTICALS, INC. (RCKT). They have made 2 open-market trades across 1 company since 2018, most recently 2020-12-10.
CIK 0001725743
2 open-market purchases totalling $18.9M since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RCKT | 17,530,044 | $38.1M |
Shares reported on the most recent Form 4, priced at the 2020-12-14 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.